Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) drew a synopsis of meaningful financial and research achievements in its annual report for the fiscal year 2023 ending Aug. 31, culminating in an agreement to be acquired by Exopharm Limited, an Australian Securities Exchange-listed company. Throughout 2023, the biotechnology company, which focuses on …
New York City‘s first legal adult-use dispensary, Housing Works Cannabis Co. logged $24 million in sales in its first year of business. That’s a significant portion of the $137 million in sales that the New York Cannabis Control Board reported for the entire state as of early December, according to …
Yet another turbulent but victory-filled 12 months for many in the cannabis trade is behind us, and plenty of business leaders are ready to focus on 2024. “The forthcoming year will be the most exciting ever in the industry,” said Morgan Paxhia, co-founder and managing director of Poseidon Investment Management. …
There’s an old adage in journalism: If it bleeds, it leads. But there’s plenty of good news in our top stories of the past year, including the most-read story of the last 12 months. Here are the top stories from Green Market Report this year, based on page views: 1. …